BCL2 and cancer: Due to the neutralization of a broad spectrum of proapoptotic Bcl-2 proteins, Mcl-1 may compensate for the loss of other antiapoptotic Bcl-2 proteins in tumor cells, suggesting it as a potential key regulator of antiapoptotic control in cancer cells.